Prevention of diabetes: A reality in primary care?

References 

1. International Diabetes Federation. 2006. Diabetes Atlas. http://www.eatlas.idf.org/media/Accessed2007/06/20.
2. Morgan CL, Currie CJ, Peters JR. Relationship between diabetes and mortality: A population study using record linkage. Diab. Care. 2000;23:1103–1107
3. Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin. Ther. 2004;26:304–321
   • Abstract
   • Full-Text PDF (144 KB)
   • CrossRef
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403
   • CrossRef
5. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001;344:1343–1350
   • MEDLINE
   • CrossRef
6. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: Systematic review and meta-analysis. BMJ. 2007;334:299–308
   • CrossRef
7. Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diab. Care. 2003;26:2518–2523
8. Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC. The fasting hyperglycaemia study: II. randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism. 1997;46:50–55
   • Abstract
   • Full-Text PDF (644 KB)
   • CrossRef
9. Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KG. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diab. Res. Clin. Pr. 2006;72:117–127
10. Davies MJ, Tringham JR, Troughton J, Khunti KK. Prevention of type 2 diabetes mellitus. A review of the evidence and its application in a UK setting. Diab. Med. 2004;21:403–414
11. Icks A, Rathmann W, Haastert B, Gandjour A, Holle R, John J, et al. Clinical and cost-effectiveness of primary prevention of type 2 diabetes in a ’real world’ routine healthcare setting: Model based on the KORA survey 2002. Diab. Med. 2007;24:473–480
12. Lindström J, Tuomilehto J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diab. Care. 2003;26:725–731
13. Yates T, Khunti K, Bull F, Gorely T, Davies MJ. The role of physical activity in the management of impaired glucose tolerance: A systematic review. Diabetologia. 2007;50:1116–1126
    • MEDLINE
    • CrossRef
14. Rothman A. Is there nothing more practical than a good theory?”: Why innovations and advances in health behaviour change will arise if interventions are used to test and refine theory. Int. J. Behav. Nutr. Phys. Activity. 2004;1:11
15. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–2475
    • MEDLINE
    • CrossRef
16. Bandura A. The primacy of self-regulation in health promotion. Appl. Psychol. Rev. 2005;54:245–254